2016-09-22T12:23:32-05:00 2015-12-31 BDO USA LLP 1100 Peachtree Street Suite 700 ATLANTA GA 303094516 990 2015-01-01 581341679 Arthritis Foundation Inc % JANE BASCLE VP OF FINANCE ARTH 4048727100 1355 Peachtree Street NE Suite 600 Atlanta GA 30309 DAVID MCLOUGHLIN COO COO 4048727100 2016-09-22 true Sandra L Feinsmith P01064157 4046886841 2015 2017-02-10 21:41:12Z X Ann Palmer CEO 1355 Peachtree St ne suite 600 Atlanta GA 30309 69491555 false 8510 X www.arthritis.org X 1948 GA THE MISSION OF THE ARTHRITIS FOUNDATION IS TO IMPROVE LIVES THROUGH LEADERSHIP IN PREVENTION, CONTROL AND CURE OF ARTHRITIS AND RELATED DISEASES. 33 33 297 7655 6225433 10687 42556795 52731599 5757499 92646 1281380 3719205 4887757 7226021 54483431 63769471 7093347 8027341 0 0 13799005 19495799 2232604 10359 7467666 23900608 33804698 47025564 61338197 7457867 2431274 66995112 96193719 24008837 27438253 42986275 68755466 X THE MISSION OF THE ARTHRITIS FOUNDATION IS TO IMPROVE LIVES THROUGH LEADERSHIP IN PREVENTION, CONTROL AND CURE OF ARTHRITIS AND RELATED DISEASES. false false 24570139 30675 Advocacy and Access: Advocacy is one of the four pillars of the Arthritis Foundation. Our mission is to be the voice of people with Arthritis with policy makers, elected officials, regulators, at all levels of government, and employers. We do this by engaging our community of advocates in legislative and regulatory policy making, helping them to find their voices through advocacy training, meetings with Congressional representatives and state officials to ensure access to timely, affordable access to treatments and medications. Part of our advocacy program also includes the Arthritis Ambassador Program to strengthen relationships with members of Congress through advocacy training and relationship development. A new focus of the advocacy program is active engagement by our advocates in policymaking at the state level. In addition, the Arthritis Foundation is working to ensure that research funding for arthritis is increased and that there is recognition of the fact that this disease impacts one in four Americans. 10448823 7968591 Scientific Discovery: For almost 70 years, the Arthritis Foundation has initiated and supported scientific discoveries that improve the lives of people with arthritis and related diseases. The Arthritis Foundation continues to lead the way in advancing scientific discoveries and seeking solutions that will positively impact the lives of those who suffer. Our commitment to finding a cure is unwavering. The scientific strategy is the direction the Arthritis Foundation Science Department is going over the next five years. The scientific strategy has three pillars. The goal for each pillar is listed below. Pillar #1: Delivering on Discovery Improved decision making and better lives through improved prevention, earlier diagnosis and new treatments to prevent, control and cure arthritis and related diseases. Pillar #2: Decision Making With Metrics Fact-based metrics for decision making and guiding actions to improve the health of people across the lifespan with arthritis and related diseases. Pillar #3: Building Human Capital Scientific research pipeline is strengthened and scientific discovery is catalyzed and accelerated for arthritis and related diseases. 9209111 21627 92646 Community Health & Support: The Arthritis Foundation community programs empower people in local communities nationwide. The Foundation provides opportunities for people to connect with others with similar challenges and develop supportive relationships. The Arthritis Foundation programs include Kids and Family camps, the Juvenile Arthritis National Conference, the Walk With Ease exercise program, and exercise and aquatics programs. The people we reach through these programs and arm with information and self-management strategies have a better perspective on their disease and, in turn, better outcomes. 1221716 6448 2311887 PROFESSIONAL EDUCATION 1221716 6448 2311887 45449789 true true false true false false false false false true true false false true true false true true false false false false false true true false false true true true false false false false false false false false true false false false false false false false false true 189 0 true 297 true true true false false false false true true false false false false X 33 33 false false false false false true false true true false true true true true true true true true true true false AL AZ CA CT FL GA HI IL KS KY LA MD MA MI MN MS NH NJ NM NY NC OK OR PA RI SC TN UT VA WV WI X X JANE BASCLE VP OF FINANCE 4049657510 1355 PEACHTREE STREET NE SUITE 600 ATLANTA GA 30309 Michael V Ortman Chair 1.0 0.0 X 0 0 0 Rowland W Chang Vice Chair 1.0 0.0 X 0 0 0 Catherine T Dunlay Secretary 1.0 0.0 X 0 0 0 Laurie Stewart Treasurer 1.0 0.0 X 0 0 0 Daniel T McGowan Immediate Past Chair 1.0 0.0 X 0 0 0 K Andrew Crighton Director 1.0 0.0 X 0 0 0 Patricia Hannon Director 1.0 0.0 X 0 0 0 Frank P Longobardi Director 1.0 0.0 X 0 0 0 Cavan Redmond Director 1.0 0.0 X 0 0 0 Janalee Taylor Director 1.0 0.0 X 0 0 0 Mary Battle Director 1.0 0.0 X 0 0 0 Aaron Breitenbach DIRECTOR 1.0 0.0 X 0 0 0 Theodore Cadwell DIRECTOR 1.0 0.0 X 0 0 0 Dennis Ehling DIRECTOR 1.0 0.0 X 0 0 0 Autumn Ehnow DIRECTOR 1.0 0.0 X 0 0 0 Helen Emery DIRECTOR 1.0 0.0 X 0 0 0 E Robert Harris DIRECTOR 1.0 0.0 X 0 0 0 Randeep Kahlon DIRECTOR 1.0 0.0 X 0 0 0 Virginia Kraus DIRECTOR 1.0 0.0 X 0 0 0 Alan Lotvin DIRECTOR 1.0 0.0 X 0 0 0 Peter R Martin DIRECTOR 1.0 0.0 X 0 0 0 Michael Moriarty DIRECTOR 1.0 0.0 X 0 0 0 Matt Mooney DIRECTOR 1.0 0.0 X 0 0 0 Chris Nieto DIRECTOR 1.0 0.0 X 0 0 0 David Pleasance DIRECTOR 1.0 0.0 X 0 0 0 Kirsten Smith DIRECTOR 1.0 0.0 X 0 0 0 Walter Smith DIRECTOR 1.0 0.0 X 0 0 0 Suzanne Taylor Director 1.0 0.0 X 0 0 0 Peter Vican DIRECTOR 1.0 0.0 X 0 0 0 Jennifer Vido DIRECTOR 1.0 0.0 X 0 0 0 Dan Wenger DIRECTOR 1.0 0.0 X 0 0 0 W Hayes Wilson DIRECTOR 1.0 0.0 X 0 0 0 Bryon Wornson DIRECTOR 1.0 0.0 X 0 0 0 Karen Larson Chief Financial Officer 40.0 0.0 X 218113 0 21131 Ann Palmer President/CEO 40.0 0.0 X 517036 0 43756 Meagan Fulmer Chief Development Officer 40.0 0.0 X 232639 0 18946 Wayne Guthrie Sr. VP, Staff Operations 40.0 0.0 X 208742 0 17988 Sandra Mackey Sr. VP, Marketing & Comm 40.0 0.0 X 208844 0 19416 Cindy McDaniel Sr. VP, Consumer Health 40.0 0.0 X 209050 0 30293 Amanda Niskar National Scientific Director 40.0 0.0 X 226589 0 19191 Sandie Preiss VP, Advocacy & Access 40.0 0.0 X 206236 0 18670 Marla Davidson VP, Information Technology 40.0 0.0 X 195127 0 23727 Richard Willis VP, Strategic Affairs 40.0 0.0 X 173043 0 15081 Elizabeth Phillips VP, Cause Development 40.0 0.0 X 166334 0 12907 2561753 0 241106 11 false true false Merkle Inc PO BOX 64897 BALTIMORE MD 212644897 direct mail counsel 8083822 QuadGraphics Inc PO Box 842858 BOSTON MA 022842858 Printing & Artwork 1403108 Blackbaud Internet Solutions Divisi PO BOX 930256 ATLANTA GA 311930256 TECH & SOFTWARE SVCS 1379139 Meredith Corporation PO Box 730148 DALLAS TX 753730148 Printing & Artwork 777605 Graphic Solutions Group PO Box 720477 ATLANTA GA 30358 Printing & Artwork 615265 21 232861 5069576 16324880 708910 30395372 203138 52731599 COMMUNITY HEALTH & SUPPORT 624100 92646 92646 92646 1331230 1331230 0 75944 75944 103760 280024 -176264 0 -176264 10045 -186309 7000000 4612025 2387975 2387975 699978 1687997 329079 5069576 830035 -500956 -500956 0 0 OTHER REVENUE 900099 2311887 2311887 ADVERTISING REVENUE 541800 5451077 5451077 SECTION 481(A) ADJUSTMENT 64333 64333 7827297 63769471 2404533 6225433 2407906 7968591 7968591 58750 58750 0 0 2802859 1548609 928491 325759 0 13227927 8474174 2995874 1757879 639055 360861 206248 71946 1628542 919604 525594 183344 1197416 752564 287991 156861 0 224840 184096 28331 12413 1678309 737399 832053 108857 603920 603920 10359 10359 0 3883830 3180027 489387 214416 601404 285808 59531 256065 6722943 5545149 884648 293146 0 0 1161821 1096969 -113406 178258 1567894 1213699 178329 175866 0 1087595 935106 71045 81444 0 6508391 4392634 642432 1473325 523028 397501 67994 57533 308855 234730 40151 33974 MEMBERSHIP/DIR RESP MKTG 7901722 5936731 58259 1906732 MISCELLANEOUS EXPENSES 1030146 622867 237790 169489 61338197 45449789 8420742 7467666 7901721 5531205 2370516 9498924 7294136 0 0 7584502 10666724 4502680 6052588 0 0 0 0 0 0 405745 301491 1092243 1161862 8389388 3267572 5434993 5121816 29559035 50137286 0 2498237 0 0 0 0 8916990 12959579 66995112 96193719 5263109 7568415 4223566 6848621 0 0 1100000 0 0 0 0 0 0 0 0 0 13422162 13021217 24008837 27438253 X 9170676 8846660 18946747 25802462 14868852 34106344 42986275 68755466 66995112 96193719 X 2431274 -3760297 27098214 X false true X true true true X 38998639 34111935 37069773 42556795 52731599 205468741 0 0 38998639 34111935 37069773 42556795 52731599 205468741 0 205468741 798359 763126 683119 888092 1500889 4633585 0 0 0 0 10687 10687 335022 -835488 -55483 27631 2311887 1783569 211896582 31549624 0.96967 0.97770 X SCHEDULE A, PART II, SECTION B, LINE 10 OTHER INCOME IS AN ACCUMULATION OF INDIVIDUALLY INSIGNIFICANT TRANSACTIONS OF REVENUE AND EXPENSES INCURRED DURING NORMAL DAY-TO-DAY OPERATIONS OF THE ORGANIZATION AND WERE NOT ORIGINALLY RECORDED IN SPECIFIC INCOME OR EXPENSE ACCOUNTS DURING THE YEAR. FOR FINANCIAL REPORTING PURPOSES THIS ACCUMULATED BALANCE WAS DEEMED IMMATERIAL AND REMAINED SEPARATELY REPORTED ON THE ORGANIZATIONS FINANCIAL STATEMENTS AS "miscellaneous revenue and losses". Additionally, a portion of other income is due to unused grant expenditures that were refunded to the organization during the year. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 241568 362352 603920 61084608 61688528 1000000 250000 1000000 1000000 1000000 1000000 4000000 6000000 421079 279353 484387 603920 1788739 250000 250000 250000 250000 1000000 1500000 189486 125709 217974 241568 774737 7295703 19983998 -314863 1122499 25842339 6451538 868460 208043 232338 7295703 5689033 979718 217213 6451538 5388928 599664 299559 5689033 6068156 -42379 636849 5388928 0.90240 0.09760 false false 407000 407000 1992130 976336 1015794 287128 117262 169866 595983 523285 72698 5107147 1650689 3456458 5121816 BENEFICIAL INT IN PERP TRUST 12959579 12959579 0 SPLIT INTEREST AGREEMENTS 8874309 FUNDS HELD IN TRUST-CHART ENT 2754236 DEBT OBLIGATIONS 73616 DUE TO CHARTERED ENTITIES 1319056 13021217 60295172 -3760297 70307 280024 -3409966 63705138 64333 64333 63769471 61688528 70307 280024 350331 61338197 61338197 PART XI, LINES 2D & 4B LINE 2D - RENT EXPENSES OF $280,024 LINE 4B - SECTION 481(A) ADJUSTMENT OF $64,333 PART XII, LINE 2D RENT EXPENSES OF $280,024 X X X X X X X true Merkle Inc PO Box 64897 Baltimore MD 212644897 Direct Mail false 10118459 8083822 2034637 MDS Communications Corp 545 W Juanita Ave Mesa AZ 85210 Direct Mail false 273736 132976 140760 Springboard Consulting 14 Glenbrook Drive Mendham NJ 07945 Corporate false 1982500 96659 1885841 12374695 8313457 4061238 All States Crystal Ball 388420 307181 81239 74389 6850 41872 Walk to a Cure 304314 299458 4856 3856 500 500 23021 90 4705921 4462937 242984 57754 163496 14472 443325 5398655 5069576 329079 61610 238385 21822 508218 830035 -500956 true CARRA INC C/O STANFORD UNIV MEDICAL CTR PALO ALTO CA 94304 464152355 501(c)(3) 4235000 research grant NOA INC 4201 collins avenue miami beach FL 33140 650519986 501(c)(3) 450000 research grant Duke University 2138 Campus Drive Durham NC 27708 560532129 501(c)(3) 377077 research grant Rush University Medical Center 1700 West Van Buren Rm277 Chicago IL 60612 362174823 501(c)(3) 354557 research grant Cleveland Clinic Foundation 9500 Euclid Avenue Cleveland OH 44195 340714585 501(c)(3) 318774 research grant University of Iowa B-5 Jessup Hall Iowa City IA 52242 426004813 501(c)(3) 317703 research grant Vanderbilt University Medical Center 1161 21st Ave S T1217 Nashville TN 37232 620476822 501(c)(3) 270000 research grant New York University School of Medicine 550 1st Avenue New York NY 10016 135562308 501(c)(3) 200000 research grant Stanford University PO Box 44253 San Francisco CA 941444253 941156365 501(c)(3) 200000 research grant The University of Tennessee-Health Science Center 920 Court Ave Memphis TN 38163 060646973 501(c)(3) 135000 research grant Baylor College of Medicine PO Box 301207 Dallas TX 75303 741613878 501(c)(3) 128862 research grant Yale University Yale University New Haven CT 06520 060646973 501(c)(3) 114860 research grant Albert Einstein College of Medicine-Yeshiva Univ 1300 Morris Park Avenue Bronx NY 10461 472209056 501(c)(3) 108000 research grant Boston University Office of Research Accounting Boston MA 02215 042103547 501(c)(3) 100000 research grant Children's Hospital of Philadelphia Research Inst PO Box 8500 Philadelphia PA 191781457 231352166 501(C)(3) 100000 research grant The Hospital for Special Surgery 535 East 70th Street New York NY 10021 131624135 501(c)(3) 100000 research grant University of California San Diego 9500 Gilman Drive La Jolla CA 92093 966006144 501(c)(3) 100000 research grant University of Colorado Denver 1250 14th St Denver CO 80202 846000555 501(c)(3) 100000 research grant University of Massachusetts Medical School 55 Lake Avenue North Worcester MA 01655 043167352 170(c)(1) 100000 research grant Washington State University PO Box 641039 Pullman WA 99164 916001108 501(c)(3) 100000 research grant arthritis foundation Great Lakes Region 3740 Ridge Mill Drive Hilliard OH 43026 274014550 501(c)(3) 21000 program grant arthritis foundation Great West Region 115 NE 100th St Suite 350 Seattle WA 98125 383826066 501(c)(3) 10000 program grant arthritis foundation Heartland Region 35 E Wacker Drive Suite 2260 Chicago IL 60601 264639290 501(c)(3) 10000 program grant arthritis foundation pacific region 800 W 6th Street Suite 1250 Los Angeles CA 90017 951885447 501(c)(3) 10000 program grant gordon scholarship 512 Liberty Ln West Kingston RI 028921502 10000 program grant arthritis foundation new england region 35 Cold Spring Road Suite 411 Rocky Hill CT 06067 042113261 501(c)(3) 7895 program grant 25 Junior Arthritis Camperships 95 58750 part i line 2 monitoring is provided by the arthritis foundation's national office through oversight of the terms and conditions of a written agreement. Multiyear agreements require yearly progress and financial reports for continuation of funding. X X X X X X false false false false false false false false false Meagan Fulmer Chief Development Officer 225139 0 7500 0 0 0 9100 0 9846 0 251585 0 0 0 Wayne Guthrie Sr. VP, Staff Operations 201242 0 7500 0 0 0 8140 0 9848 0 226730 0 0 0 Karen Larson Chief Financial Officer 210613 0 7500 0 0 0 8700 0 12431 0 239244 0 0 0 Sandra Mackey Sr. VP, Marketing & Comm 201344 0 7500 0 0 0 4842 0 14574 0 228260 0 0 0 Cindy McDaniel Sr. VP, Consumer Health 201550 0 7500 0 0 0 15480 0 14813 0 239343 0 0 0 Amanda Niskar National Scientific Director 226589 0 0 0 0 0 5180 0 14011 0 245780 0 0 0 Ann Palmer President/CEO 423536 0 85000 0 8500 0 28600 0 15156 0 560792 0 0 0 Sandie Preiss VP, Advocacy & Access 198736 0 7500 0 0 0 4608 0 14062 0 224906 0 0 0 Marla Davidson VP, Information Technology 195127 0 0 0 0 0 14578 0 9149 0 218854 0 0 0 Richard Willis VP, Strategic Affairs 173043 0 0 0 0 0 1260 0 13821 0 188124 0 0 0 Elizabeth Phillips VP, Cause Development 166334 0 0 0 0 0 0 0 12907 0 179241 0 0 0 X 21 203138 STOCK EXCHANGE VALUE false true true PART I, LINE 32b AUTOS FOR ARTHRITIS-ADVANCED REMARKETING SERVICES DELIVERS PROFESSIONAL REMARKETING SERVICES TO THE ARTHRITIS FOUNDATIONS CAR DONATION PROGRAMS. SERVICES INCLUDE STATE OF THE ART CALL CENTER, NATIONWIDE TOWING COVERAGE, ESTABLISHED NETWORK OF BUYERS AND AUCTIONS, COMPREHENSIVE REPORTING AND PROCESSING OF ALL REQUIRED STATE AND IRS DOCUMENTS. FUNDS COLLECTED (GROSS, LESS APPLICABLE FEES) ARE DIRECT DEPOSITED INTO THE NATIONAL OFFICE BANK ACCOUNT. NATIONAL OFFICE ACCOUNTING STAFF HAS BEEN GIVEN ACCESS TO THE ONLINE REPORT SYSTEM TO GENERATE REPORTS USED TO DISBURSE FUNDS TO THE APPROPRIATE CHARTERED ENTITIES BASED ON THE DONOR ZIP CODE. FORM 990, PART VI, SECTION A, LINE 1 THE EXECUTIVE COMMITTEE HAS BEEN GIVEN THE AUTHORITY TO EXERCISE ANY AND ALL POWERS OF THE NATIONAL BOARD BETWEEN MEETINGS OF THE FULL NATIONAL BOARD. THE EXECUTIVE COMMITTEE CONSISTS OF THE OFFICERS AND UP TO EIGHT ADDITIONAL DIRECTORS. FORM 990, PART VI, SECTION A, LINE 7a TWENTY MEMBERS OF THE FOUNDATIONS BOARD OF DIRECTORS ARE ELECTED BY THE REGIONAL CORPORATIONS AS EACH REGION HAS THE RIGHT TO ELECT TWO MEMBERS. FORM 990, PART VI, SECTION B, LINE 11 THE FORM 990 WAS PREPARED BY A PUBLIC ACCOUNTING FIRM WITH INPUT FROM THE FOUNDATION'S ACCOUNTING STAFF AND CFO. A DRAFT COPY OF THE FORM 990 WAS REVIEWED BY KEY ACCOUNTING STAFF AND SENIOR MANAGEMENT. EACH PERSON INDIVIDUALLY REVIEWED THE FORM (INCLUDING SCHEDULES) AND SUBMITTED QUESTIONS OR COMMENTS TO MANAGEMENT AS NECESSARY. QUESTIONS AND COMMENTS WERE RESOLVED APPROPRIATELY TO THE SATISFACTION OF THE FOUNDATIONS CFO. THE FORM 990 (INCLUDING SCHEDULES) WAS THEN REVIEWED AND APPROVED BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS PRIOR TO SUBMISSION. THE FINAL FORM WAS PROVIDED TO THE ENTIRE BOARD OF DIRECTORS at A SCHEDULED MEETING. COMMENTS AND SUGGESTED CHANGES WERE INCORPORATED INTO A SUBSEQUENT DRAFT OF THE FORM 990. THE FINAL DRAFT OF THE FORM 990 WAS PRESENTED TO THE FULL BOARD OF DIRECTORS PRIOR TO SUBMISSION. THE FINAL FORM WAS PROVIDED TO THE ENTIRE BOARD OF DIRECTORS PRIOR TO FILING. THE FORM IS FILED AFTER REVIEW BEFORE THE ENTIRE BOARD AT A SCHEDULED MEETING. FORM 990, PART VI, SECTION B, LINE 12c AT LEAST ANNUALLY, ALL EMPLOYEES MUST SIGN A CONFLICT OF INTEREST DISCLOSURE FORM. VOLUNTEERS IN POSITIONS OF GOVERNANCE SUCH AS FOR BOARD MEMBERS, COMMITTEE MEMBERS AND AD HOC TASK FORCE MEMBERS SHALL COMPLETE A CONFLICT OF INTEREST DISCLOSURE FORM ANNUALLY AND PRIOR TO INITIAL APPOINTMENT TO SERVE IN THE VARIOUS POSITIONS. THE BOARD OF DIRECTORS AUDIT COMMITTEE REVIEWS AND ADJUDICATES POTENTIAL VOLUNTEER CONFLICTS. IF POTENTIAL CONFLICTS EXIST AS TO ARTHRITIS FOUNDATION STAFF, THE APPROPRIATE MANAGEMENT AND/OR THE HUMAN RESOURCES DEPARTMENT SHALL ADDRESS THEM. FORM 990, PART VI, SECTION B, LINE 15 THE COMPENSATION AND PERSONNEL COMMITTEE MET ON october 26, 2015 TO REVIEW TOTAL COMPENSATION AND BENEFITS FOR THE CEO AND SIX OTHER KEY EMPLOYEES. THE COMMITTEE RECEIVED COMPENSATION REPORTS PREPARED BY AN INDEPENDENT COMPENSATION CONSULTANT, JAMES E ROCCO ASSOCIATES, AND REVIEWED THE COMPARATIVE ANALYSIS OF MARKET DATA FOR PEER ORGANIZATIONS WITH THE TOTAL COMPENSATION PAID BY THE ARTHRITIS FOUNDATION FOR EACH POSITION. IT WAS THE CONSULTANTS UNRESERVED OPINION THAT THE BASE SALARIES AND TOTAL COMPENSATION PROVIDED TO THE FOUNDATIONS EIGHT SENIOR MANAGEMENT EXECUTIVES, INCLUDING THE CEO, MEET ALL STANDARDS OF REASONABLENESS AND ARE NOT EXCESSIVE. THE COMMITTEE MEETS ANNUALLY TO COMPLETE THIS REVIEW AND REPORTS TO THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES PUBLIC THE MAJORITY OF ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS VIA THE NATIONAL OFFICES WEBSITE AT WWW.ARTHRITIS.ORG. ALL OTHER DOCUMENTS NOT READILY AVAILABLE VIA THIS WEBSITE ARE AVAILABLE UPON REQUEST. FORM 990, PART XI, LINE 9 NET CHANGE IN VALUATION OF SPLIT INTEREST AGREEMENT - $1,332,919 TRANSFERS OF ASSETS FROM MID-ATLANTIC REGION - $20,310,073 TRANSFERS OF ASSETS FROM FLORIDA REGION - $4,927,212 NET CHANGE IN PENSION LIABILITY - $592,343 SECTION 481(A) ADJUSTMENT - ($64,333)